Tagomics secures 6.7M euros to revolutionize disease diagnosis with multiomics
Longevity Technology - 21-Feb-2024Unlocking a new era of comprehensive disease insights and treatment strategies
Join the club for FREE to access the whole archive and other member benefits.
CEO and Co-founder at Tagomics
Jack Kennefick is the Chief Executive Officer & Co-founder at Tagomics. His main focus is on harnessing the power of multiomics to advance disease understanding, detection and treatment.
Jack holds a Masters degree in Molecular Biotechnology and PhD in Epigenetics from University of Birmingham.
Visit website: https://tagomics.com/who-we-are/#JackKennefick
See also: Tagomics - Using multiomics for comprehensive disease insight and diagnosis
Details last updated 01-Apr-2024
Unlocking a new era of comprehensive disease insights and treatment strategies